{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:22:04Z","timestamp":1787584924357,"version":"build-2736575974"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T00:00:00Z","timestamp":1538524800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570835"],"award-info":[{"award-number":["81570835"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0204263","type":"journal-article","created":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T14:00:07Z","timestamp":1538575207000},"page":"e0204263","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Systemic inflammation and eye diseases. The Beijing Eye Study"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2972-5227","authenticated-orcid":true,"given":"Jost B.","family":"Jonas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen Bin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya Xing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,10,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S1350-9462(01)00010-6","article-title":"An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration","volume":"20","author":"GS Hageman","year":"2001","journal-title":"Prog Retin Eye Res"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/archopht.122.4.598","article-title":"Current concepts in the pathogenesis of age-related macular degeneration","volume":"122","author":"MA Zarbin","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.preteyeres.2009.11.003","article-title":"The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited","volume":"29","author":"DH Anderson","year":"2010","journal-title":"Prog Retin Eye Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1073\/pnas.0408835103","article-title":"Drusen complement components C3a and C5a promote choroidal neovascularization","volume":"103","author":"M Nozaki","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1096\/fj.03-1476fje","article-title":"A central role for inflammation in the pathogenesis of diabetic retinopathy","volume":"18","author":"AM Joussen","year":"2004","journal-title":"FASEB J"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.preteyeres.2011.05.002","article-title":"Inflammation in diabetic retinopathy","volume":"30","author":"J Tang","year":"2011","journal-title":"Prog Retin Eye Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1167\/iovs.05-1456","article-title":"A prospective assessment of the Y402H variant in complement factor H, genetic variants in C-reactive protein, and risk of age-related macular degeneration","volume":"47","author":"DA Schaumberg","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/jama.296.3.301","article-title":"Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration","volume":"296","author":"DD Despriet","year":"2006","journal-title":"JAMA"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.ophtha.2006.12.021","article-title":"Elevated C-reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular age-related macular degeneration","volume":"114","author":"Nakamura M Kikuchi","year":"2007","journal-title":"Ophthalmology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/j.ophtha.2009.03.011","article-title":"Complement factor H Y402H and C-reactive protein polymorphism and photodynamic therapy response in age-related macular degeneration","volume":"116","author":"X Feng","year":"2009","journal-title":"Ophthalmology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.ophtha.2009.11.020","article-title":"C-reactive protein and CFH, ARMS2\/HTRA1 gene variants are independently associated with risk of macular degeneration","volume":"117","author":"JM Seddon","year":"2010","journal-title":"Ophthalmology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.ophtha.2010.02.003","article-title":"C-reactive protein levels and complement factor H polymorphism interaction in age-related macular degeneration and its progression","volume":"117","author":"L Robman","year":"2010","journal-title":"Ophthalmology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/path.4766","article-title":"Monomeric C-reactive protein and inflammation in age-related macular degeneration","volume":"240","author":"KR Chirco","year":"2016","journal-title":"J Pathol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1001\/jamaophthalmol.2017.2191","article-title":"Association of C-reactive protein genetic polymorphisms with late age-related macular degeneration","volume":"135","author":"V Cipriani","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1167\/iovs.15-16470","article-title":"Increased plasma S100A12 levels are associated with diabetic retinopathy and prognostic biomarkers of macrovascular events in type 2 diabetic patients","volume":"56","author":"N Dong","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.dsx.2016.08.012","article-title":"Association of serum high-sensitivity C-reactive protein with metabolic control and diabetic chronic vascular complications in patients with type 2 diabetes","volume":"11","author":"S Chuengsamarn","year":"2017","journal-title":"Diabetes Metab Syndr"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000488537","article-title":"Baseline high-sensitivity C-reactive protein predicts macrovascular and microvascular complications of type 2 diabetes: a population-based study","volume":"72","author":"Z Aryan","year":"2018","journal-title":"Ann Nutr Metab"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1172\/JCI200318921","article-title":"C-reactive protein: a critical update","volume":"111","author":"MB Pepys","year":"2003","journal-title":"J Clin Invest"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJMoa1107477","article-title":"C-reactive protein, fibrinogen, and cardiovascular disease prediction","volume":"367","author":"S Kaptoge","year":"2012","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/j.ophtha.2013.03.009","article-title":"Subfoveal choroidal thickness in diabetes and diabetic retinopathy","volume":"120","author":"J Xu","year":"2013","journal-title":"Ophthalmology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.ophtha.2012.09.033","article-title":"The 10-year incidence and risk factors of retinal vein occlusion: The Beijing Eye Study","volume":"120","author":"JQ Zhou","year":"2013","journal-title":"Ophthalmology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/archpsyc.1965.01720310065008","article-title":"A Self-rating depression scale","volume":"12","author":"WW Zung","year":"1965","journal-title":"Arch Gen Psychiatry"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1755-3768.2008.01385.x","article-title":"The Beijing Eye Study","volume":"87","author":"JB Jonas","year":"2009","journal-title":"Acta Ophthalmol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/bjo.86.2.238","article-title":"The definition and classification of glaucoma in prevalence surveys","volume":"86","author":"PJ Foster","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.ajo.2010.06.037","article-title":"Prevalence of glaucoma in North China. The Beijing Eye Study","volume":"150","author":"YX Wang","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"ref26","first-page":"1873","article-title":"Fundus tessellation: Prevalence and associated factors. The Beijing Eye Study 2011","volume":"122","author":"YN Yan","year":"2015","journal-title":"Ophthalmology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1161\/CIRCULATIONAHA.106.649939","article-title":"Prognostic significance of the Centers for Disease Control\/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease","volume":"115","author":"MS Sabatine","year":"2007","journal-title":"Circulation"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"5989","DOI":"10.1167\/iovs.14-14864","article-title":"Elevated plasma pentraxin 3 levels are associated with development and progression of diabetic retinopathy in Korean patients with type 2 diabetes mellitus","volume":"55","author":"HS Yang","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/dme.12640","article-title":"Circulating markers of inflammation and endothelial function, and their relationship to diabetic retinopathy","volume":"32","author":"MB Sasongko","year":"2015","journal-title":"Diabet Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3109\/02713683.2012.713153","article-title":"Associations between diabetic retinopathy and plasma levels of high-sensitive C-reactive protein or von Willebrand factor in long-term type 1 diabetic patients","volume":"38","author":"JV Laursen","year":"2013","journal-title":"Curr Eye Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12902-015-0006-5","article-title":"C-reactive protein genetic variant is associated with diabetic retinopathy in Chinese patients with type 2 diabetes","volume":"15","author":"D Peng","year":"2015","journal-title":"BMC Endocr Disord"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e0144406","DOI":"10.1371\/journal.pone.0144406","article-title":"Relationship between C-reactive protein level and diabetic retinopathy: a systematic review and meta-analysis","volume":"10","author":"J Song","year":"2015","journal-title":"PLoS One"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.1167\/iovs.09-4939","article-title":"C-reactive protein, body mass index, and diabetic retinopathy","volume":"51","author":"LS Lim","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref34","first-page":"111","article-title":"C-reactive protein and diabetic retinopathy in Chinese patients with type 2 diabetes mellitus","volume":"9","author":"XF Yang","year":"2016","journal-title":"Int J Ophthalmol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000488537","article-title":"Baseline high-sensitivity C-reactive protein predicts macrovascular and microvascular complications of Type 2 Diabetes: A population-based study","volume":"72","author":"Z Aryan","year":"2018","journal-title":"Ann Nutr Metab"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.dsx.2016.08.012","article-title":"Association of serum high-sensitivity C-reactive protein with metabolic control and diabetic chronic vascular complications in patients with type 2 diabetes","volume":"11","author":"S Chuengsamarn","year":"2017","journal-title":"Diabetes Metab Syndr"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.ophtha.2006.12.021","article-title":"Elevated C-reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular age-related macular degeneration","volume":"114","author":"M Kikuchi","year":"2007","journal-title":"Ophthalmology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"e110818","DOI":"10.1371\/journal.pone.0110818","article-title":"Hyperhomocysteinemia in patients with polypoidal choroidal vasculopathy: A case control study","volume":"9","author":"HC Cheng","year":"2014","journal-title":"PloS One"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000365487","article-title":"Aqueous humor cytokine levels in patients with polypoidal choroidal vasculopathy and neovascular age-related macular degeneration","volume":"53","author":"Y Sakurada","year":"2015","journal-title":"Ophthalmic Res"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0161-6420(00)00580-7","article-title":"Risk factors for age-related macular 325 degeneration: Pooled findings from three continents","volume":"108","author":"W Smith","year":"2001","journal-title":"Ophthalmology"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1001\/archneurol.2009.308","article-title":"Association of C-reactive protein with cognitive impairment","volume":"67","author":"JM Noble","year":"2010","journal-title":"Arch Neurol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jalz.2009.01.025","article-title":"Association of C-reactive protein with mild cognitive impairment","volume":"5","author":"RO Roberts","year":"2009","journal-title":"Alzheimers Dement"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0204263","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T13:07:47Z","timestamp":1540213667000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0204263"}},"subtitle":[],"editor":[{"given":"Guei-Sheung","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,10,3]]},"references-count":42,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,10,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0204263","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,3]]}}}